Amneal Pharmaceuticals (AMRX) Divestments (2024)

Amneal Pharmaceuticals (AMRX) recorded quarterly Divestments of $7.0 million in Q4 2024.

Amneal Pharmaceuticals (AMRX) Divestments (2024) Analysis & Trends

Amneal Pharmaceuticals' Divestments history runs 1 years deep, the most recent figure standing at $7.0 million for Q4 2024.

  • In Q4 2024, Divestments changed N/A year-over-year to $7.0 million; the TTM figure through Dec 2025 stood at $7.0 million (changed 0.0% YoY), while the FY2024 annual figure was $12.0 million, changed N/A from the prior year.
  • Divestments was $7.0 million for Q4 2024 at Amneal Pharmaceuticals.
  • In the past five years, Divestments ranged from a high of $7.0 million in Q4 2024 to a low of $7.0 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 42.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn -
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn -
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 63.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn -
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 24.21 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -
10 Amneal Pharmaceuticals 4.34 Bn 4.33 Bn 320.11 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2024 7.01 Mn